Effects of Immediate Blood Pressure Reduction on Death and Major Disability in Patients With Acute Ischemic Stroke, JAMA, vol.311, issue.5, pp.479-489, 2014. ,
DOI : 10.1001/jama.2013.282543
Effect of Blood Pressure Lowering in Early Ischemic Stroke, Stroke, vol.46, issue.7, pp.1883-1889, 2015. ,
DOI : 10.1161/STROKEAHA.115.009552
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial, The Lancet, vol.377, issue.9767, pp.741-750, 2011. ,
DOI : 10.1016/S0140-6736(11)60104-9
Statistical Analysis Plan for the ???Efficacy of Nitric Oxide in Stroke??? (ENOS) Trial, International Journal of Stroke, vol.12, issue.3, pp.372-374, 2014. ,
DOI : 10.1161/STROKEAHA.111.641423
Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial, Lancet, vol.385, issue.14, pp.617-628, 2015. ,
Feasibility of an Ambulance-Based Stroke Trial, and Safety of Glyceryl Trinitrate in Ultra-Acute Stroke: The Rapid Intervention With Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824), Stroke, vol.44, issue.11, pp.3120-3128, 2013. ,
DOI : 10.1161/STROKEAHA.113.001301
Nitrate Therapy: New Aspects Concerning Molecular Action and Tolerance, Circulation, vol.123, issue.19, pp.2132-2144, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.110.981407
S-Transnitrosylation of albumin in human plasma and blood in vitro and in vivo in the rat, Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol.1546, issue.2, pp.422-434, 2001. ,
DOI : 10.1016/S0167-4838(01)00166-2
S-Nitrosylation signaling regulates cellular protein interactions, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1820, issue.6, pp.722-729, 2012. ,
DOI : 10.1016/j.bbagen.2011.06.017
Plasma Nitrosothiols Contribute to the Systemic Vasodilator Effects of Intravenously Applied NO: Experimental and Clinical Study on the Fate of NO in Human Blood, Circulation Research, vol.91, issue.6, pp.470-477, 2002. ,
DOI : 10.1161/01.RES.0000035038.41739.CB
S-nitrosothiols as selective antithrombotic agents - possible mechanisms, British Journal of Pharmacology, vol.294, issue.1, pp.1572-1580, 2010. ,
DOI : 10.1111/j.1476-5381.2010.00670.x
S-Nitrosoglutathione Reduces Asymptomatic Embolization After Carotid Angioplasty, Circulation, vol.106, issue.24, pp.3057-3062, 2002. ,
DOI : 10.1161/01.CIR.0000041251.07332.28
The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke, Journal of Neurochemistry, vol.22, issue.2, pp.86-97, 2012. ,
DOI : 10.1111/j.1471-4159.2012.07947.x
-Nitrosoglutathione Reduces Inflammation and Protects Brain against Focal Cerebral Ischemia in a Rat Model of Experimental Stroke, Journal of Cerebral Blood Flow & Metabolism, vol.71, issue.86, pp.177-192, 2005. ,
DOI : 10.1161/01.STR.31.7.1588
URL : https://hal.archives-ouvertes.fr/hal-00109339
S-Nitrosothiols: a class of nitric oxide-donor drugs, Clinical Science, vol.98, issue.5, pp.507-520, 2000. ,
DOI : 10.1042/cs0980507
S-nitrosation/Denitrosation in Cardiovascular Pathologies: Facts and Concepts for the Rational Design of S-nitrosothiols, Current Pharmaceutical Design, vol.19, issue.3, pp.458-472, 2013. ,
DOI : 10.2174/1381612811306030458
URL : https://hal.archives-ouvertes.fr/hal-01273168
Are in situ formulations the keys for the therapeutic future of S-nitrosothiols?, European Journal of Pharmaceutics and Biopharmaceutics, vol.85, issue.3, pp.640-649, 2013. ,
DOI : 10.1016/j.ejpb.2013.08.005
URL : https://hal.archives-ouvertes.fr/hal-01273175
PLGA in situ implants formed by phase inversion: Critical physicochemical parameters to modulate drug release, Journal of Controlled Release, vol.172, issue.1, pp.292-304, 2013. ,
DOI : 10.1016/j.jconrel.2013.08.024
URL : https://hal.archives-ouvertes.fr/hal-01273194
Biodegradable Injectable In Situ Implants and Microparticles for Sustained Release of Montelukast: In Vitro Release, Pharmacokinetics, and Stability, AAPS PharmSciTech, vol.15, issue.3, pp.772-780, 2014. ,
DOI : 10.1208/s12249-014-0101-3
Structure formation and characterization of injectable drug loaded biodegradable devices: In situ implants versus in situ microparticles, European Journal of Pharmaceutical Sciences, vol.34, issue.2-3, pp.164-172, 2008. ,
DOI : 10.1016/j.ejps.2008.03.004
A complete physicochemical identity card of S-nitrosoglutathione, Curr Pharm Anal, vol.9, pp.31-42, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00807801
In vivo cerebrovascular reactivity in Wistar and Fischer 344 rat strains during aging, Am J Physiol, vol.264, pp.851-858, 1993. ,
S-nitrosoglutathione Prevents Experimental Cerebral Malaria, Journal of Neuroimmune Pharmacology, vol.32, issue.11, pp.477-487, 2012. ,
DOI : 10.1007/s11481-012-9343-6
S-Nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery, British Journal of Pharmacology, vol.63, issue.suppl II, pp.1236-1244, 2000. ,
DOI : 10.1038/sj.bjp.0703700
Vasodilators, Aortic Elasticity, and Ventricular End-Systolic Stress in Nonanesthetized, Unrestrained Rats, Hypertension, vol.30, issue.5, pp.1169-1174, 1997. ,
DOI : 10.1161/01.HYP.30.5.1169
Optimization of Multiplate?? whole blood platelet aggregometry in the Beagle dog and Wistar rat for ex vivo drug toxicity testing, Experimental and Toxicologic Pathology, vol.65, issue.5, pp.637-644, 2013. ,
DOI : 10.1016/j.etp.2012.07.003
Evaluation of anti-platelet and anti-thrombotic effects of cilostazol with PFA-100?? and Multiplate?? whole blood aggregometer in vitro, ex vivo and FeCl3-induced thrombosis models in vivo, Thrombosis Research, vol.127, issue.6, pp.565-570, 2011. ,
DOI : 10.1016/j.thromres.2011.02.004
Effect of Hawthorn (Crataegus aronia syn. Azarolus (L)) on Platelet Function in Albino Wistar Rats, Thrombosis Research, vol.130, issue.1, pp.75-80, 2012. ,
DOI : 10.1016/j.thromres.2012.01.001
Differences in Clot Preparation Determine Outcome of Recombinant Tissue Plasminogen Activator Treatment in Experimental Thromboembolic Stroke, Stroke, vol.34, issue.8, pp.2019-2024, 2003. ,
DOI : 10.1161/01.STR.0000080941.73934.30
Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats, Stroke, vol.20, issue.10, pp.1383-1390, 1989. ,
DOI : 10.1161/01.STR.20.10.1383
Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination, Stroke, vol.17, issue.3, pp.472-476, 1986. ,
DOI : 10.1161/01.STR.17.3.472
Cerebral embolic ischemia in rats: Correlation of stroke severity and functional deficit as important outcome parameter, Brain Research, vol.1130, pp.188-196, 2007. ,
DOI : 10.1016/j.brainres.2006.10.087
A Semiautomated Method for Measuring Brain Infarct Volume, Journal of Cerebral Blood Flow & Metabolism, vol.16, issue.2, pp.290-293, 1990. ,
DOI : 10.1038/jcbfm.1990.47
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences, Behavior Research Methods, vol.47, issue.2, pp.175-191, 2007. ,
DOI : 10.3758/BF03193146
Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke, Nitric Oxide, vol.15, issue.2, pp.114-124, 2006. ,
DOI : 10.1016/j.niox.2006.01.008
Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems, International Journal of Pharmaceutics, vol.212, issue.1, pp.11-18, 2001. ,
DOI : 10.1016/S0378-5173(00)00568-8
Optimized Preparation of in Situ Forming Microparticles for the Parenteral Delivery of Vinpocetine, CHEMICAL & PHARMACEUTICAL BULLETIN, vol.56, issue.6, pp.796-801, 2008. ,
DOI : 10.1248/cpb.56.796
Noninvasive characterization of in situ forming implants using diagnostic ultrasound, Journal of Controlled Release, vol.143, issue.2, pp.183-190, 2010. ,
DOI : 10.1016/j.jconrel.2010.01.001
Detection of S-nitrosothiols in biological fluids: A comparison among the most widely applied methodologies, Journal of Chromatography B, vol.851, issue.1-2, pp.124-139, 2007. ,
DOI : 10.1016/j.jchromb.2006.09.031
Determination of S-nitrosoglutathione in plasma: Comparison of two methods, Talanta, vol.81, issue.4-5, pp.1295-1299, 2010. ,
DOI : 10.1016/j.talanta.2010.02.024
In vivo evaluation of vaginal films for mucosal delivery of nitric oxide, Biomaterials, vol.30, issue.23-24, pp.3978-3985, 2009. ,
DOI : 10.1016/j.biomaterials.2009.04.004
Positive effects of nitric oxide on left ventricular function in humans, European Heart Journal, vol.27, issue.14, pp.1699-1705, 2006. ,
DOI : 10.1093/eurheartj/ehl096
S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control, Nature, vol.380, issue.6571, pp.221-226, 1996. ,
DOI : 10.1038/380221a0
S-nitroso-glutathione inhibits platelet activation in vitro and in vivo, British Journal of Pharmacology, vol.44, issue.S1, pp.745-749, 1992. ,
DOI : 10.1111/j.1476-5381.1992.tb14517.x
Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation, Blood, vol.118, issue.13, pp.3670-3679, 2011. ,
DOI : 10.1182/blood-2011-03-341107
Vascular Protection with Candesartan after Experimental Acute Stroke in Hypertensive Rats: A Dose-Response Study, Journal of Pharmacology and Experimental Therapeutics, vol.326, issue.3, pp.773-782, 2008. ,
DOI : 10.1124/jpet.108.139618
Effects of S-Nitrosoglutathione on Acute Vasoconstriction and Glutamate Release After Subarachnoid Hemorrhage ?? Editorial Comment, Stroke, vol.30, issue.9, pp.1955-1961, 1999. ,
DOI : 10.1161/01.STR.30.9.1955
Relationship Between Baseline Blood Pressure Parameters (Including Mean Pressure, Pulse Pressure, and Variability) and Early Outcome After Stroke: Data From the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST), Stroke, vol.42, issue.2, pp.491-493, 2011. ,
DOI : 10.1161/STROKEAHA.110.596163